Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observed-Reference-Cited by-同舟云学术

Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observed

Published:2020-05 Issue: Volume:134 Page:115287
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Ferrari Serge,Lewiecki E. Michael^ORCID,Butler Peter W.,Kendler David L.,Napoli Nicola,Huang Shuang,Crittenden Daria B.,Pannacciulli Nicola,Siris Ethel,Binkley Neil

Funder

Amgen Inc.

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference48 articles.

1. Changes in quality of life associated with fragility fractures: Australian arm of the International Cost and Utility Related to Osteoporotic Fractures Study (AusICUROS);Abimanyi-Ochom;Osteoporos. Int.,2015

2. The aftermath of hip fracture: discharge placement, functional status change, and mortality;Bentler;Am. J. Epidemiol.,2009

3. Compound risk of high mortality following osteoporotic fracture and refracture in elderly women and men;Bliuc;J. Bone Miner. Res.,2013

4. Impact of recent fracture on health-related quality of life in postmenopausal women;Brenneman;J. Bone Miner. Res.,2006

5. Risk of mortality following clinical fractures;Cauley;Osteoporos. Int.,2000

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of PPP1R15A alleviates osteoporosis via suppressing RANKL-induced osteoclastogenesis;Acta Pharmacologica Sinica;2024-01-08

2. Biologic Antiresorptive: Denosumab;Indian Journal of Orthopaedics;2023-12

3. Mechanistic advances in osteoporosis and anti‐osteoporosis therapies;MedComm;2023-05-11

4. Monoclonal antibodies for treatment of osteoporosis;Drugs of Today;2023-03

5. Zoledronic acid and denosumab for periprosthetic bone mineral density loss after joint arthroplasty: a systematic review and meta-analysis of randomized controlled trials;Archives of Osteoporosis;2023-02-25